Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Neurological Assessment Tools and Inflammatory Biomarkers for Predicting Cerebral Palsy in Neonatal HIE.

Created on 14 Oct 2026

Authors

Celil Yılmaz, Fatih İşleyen, İsmail Koyuncu, Osman Kipoğlu

Published in

Pediatrics international : official journal of the Japan Pediatric Society. Volume 68. Issue 1. Pages e70585.

Abstract

To evaluate temporal changes in serum interleukin-40 (IL-40), hypoxia-inducible factor-1 alpha (HIF-1α), and procalcitonin (PCT) levels between early and post-rewarming measurements in neonates with moderate-to-severe hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH), and to determine the prognostic value of these biomarkers together with the Hammersmith Neonatal Neurological Examination (HNNE), amplitude-integrated electroencephalography (aEEG), and magnetic resonance imaging (MRI) for predicting cerebral palsy (CP).
Thirty-five neonates with HIE treated with TH and 20 healthy term neonates were prospectively enrolled. Serum IL-40, HIF-1α, and PCT levels were measured before and after TH. Associations between biomarkers, HNNE, aEEG, MRI findings, and CP at follow-up were evaluated.
Serum IL-40, HIF-1α, and PCT levels decreased significantly between the early and post-rewarming measurements (all p < 0.001). Although biomarker levels differed from controls, they were not associated with subsequent CP. In contrast, HNNE, aEEG, and MRI showed strong prognostic performance for subsequent CP among surviving infants.
Serum IL-40, HIF-1α, and PCT levels showed significant temporal decreases between the early and post-rewarming measurements in neonates with HIE undergoing TH; however, these biomarkers did not predict subsequent CP among surviving infants. HNNE, aEEG, and MRI each demonstrated strong prognostic performance for subsequent CP when evaluated individually in this cohort.

PMID:
42870552
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement